Skip to main content

Weather Alert

Hurricane activity is severely impacting Quest locations across the Southeast. We ask that patients please double check your appointment status to ensure your designated Patient Service Center is operational.

Hide
Quest Diagnostics

The LS-IM Score And Its Relation To Direct Measurements Of Insulin Resistance

WCIRDC 2023

World Congress Insulin Resistance Diabetes & Cardiovascular Disease

Poster presentation: The LS-IM Score And Its Relation To Direct Measurements Of Insulin Resistance

Authors: Rowland C, Abbasi F, McPhaul MJ

Specialty: Endocrinology, Cardiology, Cardiovascular disease

Related content

Publication
Insulin Resistance Probability Score and Incident Cardiovascular Disease
Publication
The relationship between insulin resistance and ion mobility lipoprotein fractions
On-Demand Webinar
Early Identification of Type 2 Diabetes Risk for the Primary Care Setting
Test FAQ
CardioIQ® Insulin Resistance Panel with Score
Test FAQ
Insulin Intact LC MS MS

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.